SCHEMBL4729418

SCHEMBL4729418

COc1cc(CNC(=O)c2ccc(-c3cc(NC(=O)c4cc(C(C)(C)C)ccc4OC)cnc3C)cc2)cc(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
NR1H4 Q96RI1 2/20 0.44
NPC1 O15118 1/20 0.44
EPHX2 P34913 1/20 0.44
RAB9A P51151 1/20 0.44
KDM1A O60341 1/20 0.42
HDAC1 Q13547 1/20 0.42
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 2/20 0.41
TSHR P16473 1/20 0.41
BLM P54132 1/20 0.41
NAMPT P43490 2/20 0.41
CYP2C19 P33261 1/20 0.41
STIM1 Q13586 1/20 0.40
ORAI1 Q96D31 1/20 0.40
RAF1 P04049 1/20 0.40
BRAF P15056 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4729066 0.93 ROCK2 (0.50) L3MBTL1CYP3A4ROCK2CYP2D6CYP2C9
SCHEMBL4729229 0.91 MEN1 (0.52) MEN1KMT2AHDAC1NAMPTROCK2
SCHEMBL4727856 0.90 MEN1 (0.45) MEN1KMT2AL3MBTL1NR1H4NPC1
SCHEMBL4781615 0.85 HPGD (0.51) MEN1KMT2ANPC1RAB9ATSHR
SCHEMBL4727301 0.82 STIM1 (0.46) MEN1KMT2ANPC1RAB9ASTIM1
SCHEMBL4727417 0.82 STIM1 (0.44) MEN1KMT2ANR1H4STIM1ORAI1
SCHEMBL4727073 0.81 MAPK14 (0.48) RAF1BRAF
SCHEMBL4728221 0.80 HPGD (0.48) MEN1KMT2AL3MBTL1CYP1A2TSHR
SCHEMBL4727373 0.78 RAF1 (0.47) RAF1BRAFRXFP1
SCHEMBL4726226 0.77 RAF1 (0.46) MEN1KMT2ANPC1RAB9ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021388-A1 HETEROARYL DERIVATIVES AS CYTOKINE INHIBITORS KEMIA, INC. (US) 2008-02-21 WO disclosed